Hjalmar Wadström

Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice

Hjalmar Wadström, Thomas Frisell, Johan Askling · JAMA Internal Medicine · 2017 · 172 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice

Viking Huss, Hannah Bower, Hjalmar Wadström et al. · Lara D. Veeken · 2021 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden

Hjalmar Wadström, Thomas Frisell, Pär Sparén et al. · Annals of the Rheumatic Diseases · 2016 · 70 citations · Full text

Medicine, Gynecology, Oncology +17

Cervical neoplasia in systemic lupus erythematosus: a nationwide study

Hjalmar Wadström, Elizabeth V. Arkema, Christopher Sjöwall et al. · Lara D. Veeken · 2016 · 63 citations · Full text

Medicine, Immunology, Pathology +17

How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?

Hjalmar Wadström, JK Eriksson, Martin Neovius et al. · Scandinavian Journal of Rheumatology · 2014 · 53 citations

Medicine, Health Sciences, Clinical Epidemiology +10